Josephine M Norquist

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. doi request reprint Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
    Josephine M Norquist
    Department of Epidemiology, Merck Research Laboratories, UG1D 60, P O Box 1000, North Wales, PA 19454, USA
    Qual Life Res 21:1013-20. 2012
  2. pmc Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance
    Josephine M Norquist
    Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
    Hum Vaccin Immunother 8:1208-12. 2012
  3. pmc One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures
    Ronette L Kolotkin
    Obesity and Quality of Life Consulting, 762 Ninth Street 563, Durham, North Carolina 27705, USA
    Health Qual Life Outcomes 7:53. 2009
  4. ncbi request reprint Validation of a questionnaire to assess niacin-induced cutaneous flushing
    Josephine M Norquist
    Merck Research Laboratories, Department of Epidemiology, North Wales, PA 19454 2505, USA
    Curr Med Res Opin 23:1549-60. 2007
  5. doi request reprint Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia
    John F Paolini
    Merck Research Laboratories, Rahway, NJ, USA
    Am J Cardiol 101:625-30. 2008
  6. ncbi request reprint Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors
    John F Paolini
    Merck and Company, Incorporated, 126 East Lincoln Avenue, Rahway, NJ 07065, USA
    Cardiol Clin 26:547-60. 2008
  7. doi request reprint Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaire
    Daisy S Ng-Mak
    Epidemiology Department, Merck Sharp and Dohme Corp, North Wales, PA 19454, USA
    Headache 51:105-17. 2011
  8. ncbi request reprint Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis
    Nancy C Santanello
    Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    Pediatr Pulmonol 40:31-8. 2005
  9. ncbi request reprint Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis
    Nancy C Santanello
    Merck Research Laboratories, Rahway, New Jersey, USA
    Allergy Asthma Proc 27:231-9. 2006
  10. ncbi request reprint Comparing alternative Rasch-based methods vs raw scores in measuring change in health
    Josephine M Norquist
    Department of Public Health, Institute of Health Sciences, University of Oxford, Oxford, UK
    Med Care 42:I25-36. 2004

Collaborators

Detail Information

Publications14

  1. doi request reprint Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
    Josephine M Norquist
    Department of Epidemiology, Merck Research Laboratories, UG1D 60, P O Box 1000, North Wales, PA 19454, USA
    Qual Life Res 21:1013-20. 2012
    ..Understand the choice of recall period for PRO measures based on intended use, characteristics of the disease, treatment, and attributes of studies...
  2. pmc Adaptation of a previously validated vaccination report card for use in adult vaccine clinical trials to align with the 2007 FDA Toxicity Grading Scale Guidance
    Josephine M Norquist
    Merck Sharp and Dohme Corp, Whitehouse Station, NJ, USA
    Hum Vaccin Immunother 8:1208-12. 2012
    ..The revised VRC is currently being used in Merck vaccine clinical trials...
  3. pmc One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures
    Ronette L Kolotkin
    Obesity and Quality of Life Consulting, 762 Ninth Street 563, Durham, North Carolina 27705, USA
    Health Qual Life Outcomes 7:53. 2009
    ....
  4. ncbi request reprint Validation of a questionnaire to assess niacin-induced cutaneous flushing
    Josephine M Norquist
    Merck Research Laboratories, Department of Epidemiology, North Wales, PA 19454 2505, USA
    Curr Med Res Opin 23:1549-60. 2007
    ..To further characterize flushing, a patient-reported Flushing Symptom Questionnaire (FSQ) was developed and validated...
  5. doi request reprint Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia
    John F Paolini
    Merck Research Laboratories, Rahway, NJ, USA
    Am J Cardiol 101:625-30. 2008
    ..LRPT plus ERN was well tolerated. In conclusion, the significant reduction in ERN-induced flushing provided by LRPT plus ERN supports an accelerated ERN dose-advancement paradigm to achieve rapidly a 2-g dose in dyslipidemic patients...
  6. ncbi request reprint Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors
    John F Paolini
    Merck and Company, Incorporated, 126 East Lincoln Avenue, Rahway, NJ 07065, USA
    Cardiol Clin 26:547-60. 2008
    ..ER niacin/laropiprant generally is tolerated well and represents a new treatment option for dyslipidemia that offers the potential for more patients to receive the lipid-modifying and cardiovascular benefits of niacin...
  7. doi request reprint Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaire
    Daisy S Ng-Mak
    Epidemiology Department, Merck Sharp and Dohme Corp, North Wales, PA 19454, USA
    Headache 51:105-17. 2011
    ..To understand migraine postdrome by directly interviewing migraine patients with postdrome symptoms. To document these symptoms, as well as impacts, as a prelude to developing a postdrome migraine questionnaire...
  8. ncbi request reprint Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis
    Nancy C Santanello
    Merck Research Laboratories, West Point, Pennsylvania 19486, USA
    Pediatr Pulmonol 40:31-8. 2005
    ..In conclusion, the BCD provides a valid, reliable, and responsive tool for the assessment of symptoms of postacute RSV-induced bronchiolitis, capable of measuring moderate effect sizes, and demonstrating responsiveness to therapy...
  9. ncbi request reprint Validation of the nighttime symptoms score as a clinically relevant measure of allergic rhinitis
    Nancy C Santanello
    Merck Research Laboratories, Rahway, New Jersey, USA
    Allergy Asthma Proc 27:231-9. 2006
    ..Sleep quality questions measure aspects of SAR that are not captured by daytime SAR symptoms. The results show that the NSS is a valid and relevant clinical measure of the impact of nighttime sleep disturbance on AR patients...
  10. ncbi request reprint Comparing alternative Rasch-based methods vs raw scores in measuring change in health
    Josephine M Norquist
    Department of Public Health, Institute of Health Sciences, University of Oxford, Oxford, UK
    Med Care 42:I25-36. 2004
    ..To compare alternative Rasch-based approaches to the assessment of change over time through the example of an outcome measure used in total hip replacement surgery...
  11. ncbi request reprint Distribution-based criteria for change in health-related quality of life in Parkinson's disease
    Ray Fitzpatrick
    Department of Public Health, Institute of Health Sciences, University of Oxford, Old Road, Headington, Oxford OX3 7LF, UK
    J Clin Epidemiol 57:40-4. 2004
    ....
  12. ncbi request reprint Some considerations for the interpretation of health-related quality of life data
    Josephine M Norquist
    Value Health 8:80-1. 2005
  13. ncbi request reprint Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration
    Josephine M Norquist
    Department of Public Health, University of Oxford, Oxford, UK
    Qual Life Res 13:1409-14. 2004
    ....
  14. ncbi request reprint Rasch scoring of outcomes of total hip replacement
    Ray Fitzpatrick
    Department of Public Health, Institute of Health Sciences, University of Oxford, Headington, Oxford OX3 7LF, United Kingdom
    J Clin Epidemiol 56:68-74. 2003
    ..Considerable gains in precision were achieved with Rasch scoring methods when groups were compared in a cross-sectional way. Alternative approaches to scoring questionnaires should be investigated to better assess comparisons over time...